FDA accepts Viatris drug application for fast-acting meloxicam pain treatment

Go back to FDA accepts Viatris drug application for fast-acting meloxicam pain treatment
(NASDAQ: VTRS) Delayed: 15.37 --0 (-0%)
Previous Close $15.37    52 Week High
Open $15.37    52 Week Low
Day High $15.37    P/E N/A 
Day Low $15.37    EPS
Volume 93